Concepedia

5-Year Results of a Randomized Comparison of XIENCE V Everolimus-Eluting and TAXUS Paclitaxel-Eluting Stents

Hemal Gada, Ajay J. Kirtane, William Newman, Mark Sanz, James Hermiller, Kenneth W. Mahaffey, Donald E. Cutlip, Krishnankutty Sudhir, Liming Hou, Kai Koo,

JACC: Cardiovascular Interventions · 2013 · 211 citations · 5 references

DOI

Concepts

References

5

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease

Gregg W. Stone, Ali A. Rizvi, William Newman et al. · New England Journal of Medicine · 2010 · 896 citations · Full text

, , +15

Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial

Elvin Kedhi, Kaiyum Sheik Joesoef, Eugène McFadden et al. · The Lancet · 2010 · 687 citations

, , +9

Comparison of an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients With Coronary Artery Disease

Gregg W. Stone · JAMA · 2008 · 584 citations

, , +15

Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents

Gregg W. Stone, Mark Midei, William Newman et al. · Circulation · 2009 · 297 citations · Full text

, , +17

Long-Term (Three-Year) Safety and Efficacy of Everolimus-Eluting Stents Compared to Paclitaxel-Eluting Stents (from the SPIRIT III Trial)

Robert J. Applegate, Manejeh Yaqub, James Hermiller et al. · The American Journal of Cardiology · 2011 · 41 citations

, , +13